Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old

NCT01730378 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

131

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Prepandrix™
BIOLOGICAL: Fluarix™

Sponsor

GlaxoSmithKline